El costo y la rentabilidad de la niñez Tratamiento del Cáncer en El Salvador, Centro América: un informe desde el cáncer infantil Red 2030
Palabras clave:
Cáncer, Costo-efectividad, Evaluación económica, Oncológico servicios, Hospitales pediátricosResumen
Fondo Aunque estudios previos han examinado el costo de tratar cánceres infantiles individuales en familias de ingresos bajos y medianos países, según el conocimiento de los autores, ninguno ha examinado la costo y rentabilidad de operar un tratamiento de cáncer infantil centro. Aquí, los autores examinaron el costo y las fuentes de financiamiento de una unidad oncológica pediátrica en el Hospital Nacional de Niños Benjamin Bloom en El Salvador, y hacer estimaciones de costo-efectividad
Descargas
Citas
Smith MA, Seibel NL, Altekruse SF, et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol. 2010; 28:2625-2634
Rodriguez-Galindo C, Friedrich P, Alcasabas P, et al. Toward the cure of all children with cancer through collaborative efforts: pediatric oncology as a global challenge. J Clin Oncol 2015; 33:3065- 073. 3. Ji X, Xuan Y, Li J, et al. Direct costs for retinoblastoma treatment during the first year of comprehensive therapy in China. J Pediatr Ophthalmol Strabismus. 2012; 49:353-358
Luo XQ, Ke ZY, Guan XQ, Zhang YC, Huang LB, Zhu J. The comparison of outcome and cost of three protocols for childhood non-high risk acute lymphoblastic leukemia in China. Pediatric Blood Cancer. 2008; 51:204-209.
Stefan DC, Stones D. How much does it cost to treat children with Hodgkin lymphoma in Africa? Leuk Lymphoma. 2009; 50:196-199
Garcia M, Chicaiza LA, Quitian H, Linares A, Ramirez O. Costeffectiveness of consolidation treatments for acute myeloid leukemia in high-risk pediatric patients within the Colombian healthcare system [in Spanish]. Biomedica. 2015; 35:549-556
Garcia-Molina M, Chicaiza-Becerra L, Moreno-Calderon A, Prieto- Martinez V, Sarmiento-Urbina I, Linares-Ballesteros A. 18FDGPET/ CT cost-effectiveness compared to CT at the end of treatment in pediatric Hodgkin’s lymphoma patients [in Spanish]. Rev Salud Publica (Bogota). 2014; 16:260-269.
Hospital Nacional de Ninos Benjamin Bloom. Hospital services. http://www.hospitalbloom.gov.sv/principal/historia.html. Accessed February 7, 2017.
Tangka FK, Subramanian S, Edwards P, et al; Cancer registration economic evaluation participants. Resource requirements for cancer registration in areas with limited resources: analysis of cost data from four low- and middle-income countries. Cancer Epidemiol. 2016; 45(suppl 1):S50-S58.
Gupta S, et al. Pediatric oncology as the next global child health priority: The need for national childhood cancer strategies in lowand middle-income countries. PLoS Med. 2014; 11:e1001656
World Health Organization. Health service delivery costs. WHOCHOICE unit cost estimates for service delivery. http:// www.who. int/choice/cost-effectiveness/inputs/health_service/ en/. Accessed April 21, 2017
US Department of Labor. Bureau of Labor Statistics. Consumer Price Index (all urban consumers) current series. https://data. bls.gov/ cgi-bin/surveymost. Accessed May 4, 2017.
Republic of El Salvador. MorbiMortalidad Estradisticas Vitales (SIMMOW). http://simmow.salud.gob.sv/. Accessed May 7, 2017
Murray CJ, Lopez AD, World Health Organization. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Global Burden of Disease and Injury Series, Vol II. Cambridge, MA: Harvard School of Public Health; 1996.
Yeh JM, Hanmer J, Ward ZJ, et al. Chronic conditions and utility based health-related quality of life in adult childhood cancer survivors. J Natl Cancer Inst. 2016; 108(9).
US Department of Health and Human Services, Agency for Healthcare Research and Quality. Medical Expenditure Panel survey. https://meps.ahrq.gov/mepsweb/. Accessed May 7, 2017
Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006; 355:1572-1582.
Bhakta N, Martiniuk AL, Gupta S, Howard SC. The cost effectiveness of treating paediatric cancer in low-income and middle- income countries: a case-study approach using acute lymphocytic leukaemia in Brazil and Burkitt lymphoma in Malawi. Arch Dis Child. 2013; 98:155-160
Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted lifeyears for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol. 2017; 3:524-548
Armstrong GT, Yasui Y, Robison LL. Reduction in late mortality after childhood cancer. N Engl J Med. 2016; 375:290-292.
Yeh JM, Nekhlyudov L, Goldie SJ, Mertens AC, Diller L. A modelbased estimate of cumulative excess mortality in survivors of childhood cancer. Ann Intern Med. 2010; 152:409-417, W131-W138
World Bank. World Bank open data. http://data.worldbank. org/. Accessed April 21, 2017.
Antillon F, Baez FL, Barr R, et al. AMOR: a proposed cooperative effort to improve outcomes of childhood cancer in Central America. Pediatr Blood Cancer. 2005; 45:107-110
Ribeiro RC, Antillon F, Pedrosa F, Pui CH. Global pediatric oncology: lessons from partnerships between high-income countries and low- to mid-income countries. J Clin Oncol. 2016; 34:53-61
Salaverria C, Rossell N, Hernandez A, et al. Interventions targeting absences increase adherence and reduce abandonment of childhood cancer treatment in El Salvador. Pediatr Blood Cancer. 2015;62: 1609-1615.
Bonilla M, Rossell N, Salaverria C, et al. Prevalence and predictors of abandonment of therapy among children with cancer in El Salvador. Int J Cancer. 2009; 125:2144-2146.
Gupta S, Yeh S, Martiniuk A, et al. The magnitude and predictors of abandonment of therapy in paediatric acute leukaemia in middleincome countries: a systematic review and meta-analysis. Eur J Cancer. 2013;49:2555-2564
Weaver MS, Howard SC, Lam CG. Defining and distinguishing treatment abandonment in patients with cancer. J Pediatr Hematol Oncol. 2015; 37:252-256
Arora RS, Eden T, Pizer B. The problem of treatment abandonment in children from developing countries with cancer. Pediatr Blood Cancer. 2007; 49:941-946
Armstrong GT, Liu Q, Yasui Y, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol. 2009; 27:2328-2338
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Los textos académicos y científicos que se publican en la Revista La Universidad están protegidos bajo la licencia CC BY NC SA 4.0, esta permite usar una obra para crear otra obra o contenido, modificando o no la obra original, siempre que se cite al autor, la obra resultante se comparta bajo el mismo tipo de licencia y no tenga fines comerciales (https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es) . El autor es el único que pose los derechos de publicación y la Revista La Universidad posee los derechos de difusión.
